Skip to main content

Ionis to present at upcoming investor conferences

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

  • 24th Annual Needham Virtual Healthcare Conference on Monday, April 7, 2025
  • Bank of America 2025 Health Care Conference on Wednesday, May 14, 2025
  • 2025 RBC Capital Markets Global Healthcare Conference on Wednesday, May 21, 2025

A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events. Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals

For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has six marketed medicines and a leading pipeline in neurology, cardiology and select areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter), LinkedIn and Instagram.

Contacts

Ionis Pharmaceuticals Investor Contact:

D. Wade Walke, Ph.D. – ir@ionis.com760-603-2331



Ionis Pharmaceuticals Media Contact:

Hayley Soffer – media@ionis.com – 760-603-4679

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.59
+0.05 (0.02%)
AAPL  273.76
-0.35 (-0.13%)
AMD  208.85
+1.27 (0.61%)
BAC  55.00
-0.33 (-0.60%)
GOOG  306.08
-3.24 (-1.05%)
META  653.97
+6.46 (1.00%)
MSFT  475.67
+0.85 (0.18%)
NVDA  177.45
+1.16 (0.66%)
ORCL  189.48
+4.56 (2.46%)
TSLA  479.75
+4.44 (0.93%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.